Navigation Links
Smith & Nephew Launches R3(TM) Acetabular System a Revolution in Hip Motion

MEMPHIS, Tenn. and SAN FRANCISCO, March 6 /PRNewswire-FirstCall/ -- Smith & Nephew, Inc. (NYSE: SNN; LSE: SN) Orthopaedic Reconstruction business today announced the global launch of the R3(TM) Acetabular System, an advanced multi-bearing acetabular cup system used in total hip replacement procedures. The announcement was made during the 75th annual American Academy of Orthopaedic Surgeons (AAOS), the largest orthopaedic congress in the world, in San Francisco.

The R3 Acetabular Cup is engineered for multiple bearing options and features STIKTITE(TM) porous coating that is designed to enhance fixation and bony in-growth. The multi-bearing cup, in addition to providing flexibility for surgeons, provides a foundation designed to reduce wear and the subsequent need for revision surgery. Optimized inserts accommodate larger head sizes and help the R3 system achieve a greater range of motion. By utilizing a single set of instruments for all bearings and as the first system for Smith & Nephew to offer disposable trial liners, the R3 Acetabular system gives surgeons one way to think differently.

"The R3 System is another example of our continuum of care in action. A surgeon now has more options to treat the patient and when combined with our excellent hip stems, the R3 system presents a high performance option that fits nicely into our growing portfolio of products for active patients," said Joseph DeVivo, president of Smith & Nephew Orthopaedic Reconstruction. "The R3 system represents how we listen to our customers and provide them with high tech answers to help their patients regain their lives."

"The R3 Acetabular system will now give me the flexibility to tailor the implant to each of my patients," said designer surgeon, Stephen McMahon, of the Malabar Orthopaedic Clinic in Windsor, Australia. "This range of options allows me to provide the most suitable surgical solution for each individual, enabling patients to realize their best possible outcome."

R3 modular resurfacing system and ceramic-on-ceramic system are currently awaiting FDA approval in the US.

(TM) Trademark of Smith & Nephew. Reg. U.S. Pat. & Tm. Off.

About us

Smith & Nephew is a global medical technology business, specializing in Orthopaedic Reconstruction, Orthopaedic Trauma & Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The company has 8,800 employees and operates in 32 countries around the world. Annual Sales in 2007 were nearly $3.4 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim," "plan," "intend," "anticipate," "well-placed," "believe," "estimate," "expect," "target," "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward- looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

SOURCE Smith & Nephew, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding
2. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
3. Smith & Nephew Introduces New Biologic to Speed Healing
4. Smith & Nephew Announces Breakthrough VERILAST(TM) Technology
5. Robert H. Smith Feeding the Future with $15 Million Gift to Hebrew University of Jerusalem
6. Smith & Nephew Wins OXINIUM(TM) Approval in Japan
7. Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced
8. Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes(TM) Tour To Feed New Orleans Families
9. EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
10. Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes(TM) Tour to L.A.
11. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
Post Your Comments:
(Date:11/24/2015)... ... , ... In response to recent news highlighting Oxycodone fraud, Novus Medical Detox ... United States grew 400 percent between 1999 and 2010, far more than the combined ... of all fatal drug overdoses. (1) , While oxycodone and the extended release form ...
(Date:11/24/2015)... AL (PRWEB) , ... November 24, 2015 , ... American ... announced today the opening of a holiday pop-up clinic located in Metro Atlanta’s North ... needs in a new and different way. The location is scheduled to operate through ...
(Date:11/24/2015)... ... November 24, 2015 , ... Cold Shoulder , LLC launched their Pro Vest, the ... and hit their goal of $20,000 in under 10 hours. , The ... new PRO Weight Loss Vest to the market. , The PRO Vest provides consumers with ...
(Date:11/24/2015)... ... November 24, 2015 , ... Sir ... customer service: the TrustDale certification. The award recognizes good companies for excellence in ... , tile and grout, and hard surface restoration company earned this recognition after ...
(Date:11/24/2015)... ... 24, 2015 , ... Dr. Kevin Day, local family chiropractor in Warsaw ... this holiday season. During the Indiana winter months, Vitamin D deficiency can lead ... at AlignLife want to help provide the tools needed to combat it this year! ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ESSA Pharma ... EPIX ) announced today that the first patient has ... EPI-506 as a treatment for metastatic castration-resistant prostate cancer ... and Canada.  --> the United ... In the Phase 1/2 clinical trial, ESSA intends to ...
(Date:11/24/2015)... New York , 24. November 2015 ... des Avery Breathing Pacemaker Systems, ist erfreut, ... als Clinical Consultant bekannt geben zu können. ...   --> Foto ... Stockholm (Schweden). Von 1984-1986 war ...
Breaking Medicine Technology: